Eliminating reimbursement gaps may reduce the healthcare and outcome disparities experienced by these underserved groups, ACR-affiliated researchers reported. 

SNMMI President Cathy Cutler, PhD, explains some of the key policy initiatives the society is pursuing to help support the field of nuclear medicine. 

With the growing demand for virtual care and an increasingly mobile population, the need to improve communication with non-English-speaking patients is immense. 

Boston Scientific is recalling the catheters associated with its POLARx Cryoablation System due to a heightened risk of esophageal injury. The FDA has ruled that this a Class I recall.

Society of Nuclear Medicine and Molecular Imaging President, Cathy Cutler, explains the long road to jump-starting a new U.S. domestic supply of imaging isotopes.

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

More than 100 plaintiffs have now sued the Marlborough, Massachusetts-based mammography-maker, claiming they suffered injuries and emotional distress stemming from implantation of the BioZorb radiographic marker. 

“With this signal about the public’s preference for notification, the question for health systems and policymakers is not whether to notify patients but when and how.” 

BAV patients are often excluded from TAVR trials, creating uncertainty about the best way to treat that population when aortic valve replacement is required. To learn more, researchers tracked CMS data from 2018 to 2022, presenting their findings in The Annals of Thoracic Surgery.

An additional 15 patients will now receive BiVacor's titanium total artificial heart technology as they wait for a permanent transplant.